SCHEMBL903788

SCHEMBL903788

Oc1cc(Br)ccc1-c1[nH]c2ccc(Cl)cc2c1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.46
HTR2C P28335 2/20 0.46
HTR2B P41595 2/20 0.46
MGLL Q99685 2/20 0.44
MAP4K1 Q92918 1/20 0.44
AR P10275 1/20 0.43
DAO P14920 1/20 0.39
CCNB2 O95067 3/20 0.39
CDK1 P06493 3/20 0.39
CCNB1 P14635 3/20 0.39
GSK3B P49841 3/20 0.39
CCNB3 Q8WWL7 3/20 0.39
CDK5 Q00535 2/20 0.39
CDK5R1 Q15078 2/20 0.39
GUSB P08236 1/20 0.39
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA4 P22748 2/20 0.38
CA6 P23280 2/20 0.38
GAA P10253 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL903408 0.92 AR (0.50) HTR2AHTR2CHTR2BMGLLAR
SCHEMBL903416 0.86 HTR2A (0.45) HTR2AHTR2CHTR2BMGLLMAP4K1
SCHEMBL10215238 0.83 AR (0.44) MGLLARCCNB2CDK1CCNB1
SCHEMBL903701 0.82 CA12 (0.40) HTR2CHTR2BMGLLDAOCCNB2
SCHEMBL903535 0.80 MGLL (0.46) HTR2AHTR2CHTR2BMGLLMAP4K1
SCHEMBL15898168 0.78 DAO (0.45) HTR2AHTR2CHTR2BMGLLMAP4K1
SCHEMBL14765050 0.75 CA1 (0.44) ARCCNB2CDK1CCNB1GSK3B
SCHEMBL903529 0.74 AR (0.50) HTR2AHTR2CHTR2BARCCNB2
SCHEMBL903498 0.74 AR (0.50) ARCCNB2CDK1CCNB1GSK3B
SCHEMBL29923100 0.73 CHUK (0.53) HTR2AHTR2CHTR2BMGLLMAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018032468-A1 HETEROCYCLE-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2018-02-22 WO disclosed
WO-2018035005-A1 HETEROCYCLE-SUBSTITUTED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2018-02-22 WO disclosed
WO-2012041014-A1 TETRACYCLIC INDOLE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION MERCK SHARP & DOHME CORP. (US) 2012-04-05 WO disclosed